drugset / Trial / NCT05361369
Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule
NaSingle-groupOpen-labelOther
Summary
A single dose of the study drug will be administered to healthy female subjects in a single period to obtain pharmacokinetic parameters for each active ingredient.
Timeline
- Start
- 2022-05-09
- Primary completion
- 2022-05-13
- Completion
- 2023-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 100 mg | Other |
| Subject | fenticonazole | Small molecule | 600 mg | Other |
| Subject | tinidazole | Small molecule | 1000 mg | Other |
Indications
No indication recorded.